Overexpression of hypoxia-inducible factor 1α induces migration and invasion through Notch signaling

International Journal of Oncology

Volumn 47, Issue 2, 2015, Pages 728-738

  Tian, Quan ^a   Xue, Yan ^a   Zheng, Wei ^a   Sun, Rong ^a   Ji, Wei ^a   Wang, Xinyang ^a   An, Ruifang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Choriocarcinoma; DAPT; HIF 1 ; Mesenchymal transition; MMP; Notch1

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH RECEPTOR; UVOMORULIN; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CELL MIGRATION; CHORIOCARCINOMA; CHORIOCARCINOMA CELL LINE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NOD SCID MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS NODULE; ANIMAL; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; PREGNANCY; TUMOR CELL LINE; TUMOR INVASION; UTERUS CANCER;

ANIMALS; CELL LINE, TUMOR; CHORIOCARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PREGNANCY; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UTERINE NEOPLASMS;

EID: 84932646538     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3056     Document Type: Article

References (44)

1. Cheung AN, Zhang HJ, Xue WC and Siu MK: Pathogenesis of choriocarcinoma: Clinical, genetic and stem cell perspectives. Future Oncol 5: 217-231, 2009.
2. Semenza GL: HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 8 (Suppl): S62-S67, 2002.
3. Shen G, Li X, Jia YF, Piazza GA and Xi Y: Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin 34: 336-341, 2013.
4. Lee JW, Bae SH, Jeong JW, Kim SH and Kim KW: Hypoxiainducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 36: 1-12, 2004.
5. Bruick RK: Oxygen sensing in the hypoxic response pathway: Regulation of the hypoxia-inducible transcription factor. Genes Dev 17: 2614-2623, 2003.
6. Semenza GL: Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol Med 7: 345-350, 2001.
7. Jiang J, Tang YL and Liang XH: EMT: A new vision of hypoxia promoting cancer progression. Cancer Biol Ther 11: 714-723, 2011.
8. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
9. Ombrato L and Malanchi I: The EMT universe: Space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog 19: 349-361, 2014.
10. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
11. Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W and Qiu L: MicroRNA-7 inhibits tumor metastasis and reverses epithelialmesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One 9: e96718, 2014.
12. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P and Batra SK: MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29: 5741-5754, 2010.
13. Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Tumor necrosis factor (TNF) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Med Oncol 29: 3083-3091, 2012.
14. Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS and Park YN: Human hepatocellular carcinomas with 'Stemness'-related marker expression: Keratin 19 expression and a poor prognosis. Hepatology 54: 1707-1717, 2011.
15. Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 132: 3151-3161, 2005.
16. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: Cell fate control and signal integration in development. Science 284: 770-776, 1999.
17. Kadesch T: Notch signaling: The demise of elegant simplicity. Curr Opin Genet Dev 14: 506-512, 2004.
18. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U and Bondesson M: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628, 2005.
19. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L and Bocchetta M: Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67: 7954-7959, 2007.
20. Fang Y, Yu S, Ma Y, Sun P, Ma D, Ji C and Kong B: Association of Dll4/notch and HIF-1-VEGF signaling in the angiogenesis of missed abortion. PLoS One 8: e70667, 2013.
21. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I and Karsan A: Jagged1-mediated Notch activation induces epithelialto-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204: 2935-2948, 2007.
22. Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105: 6392-6397, 2008.
23. Chen J, Imanaka N, Chen J and Griffin JD: Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 102: 351-360, 2010.
24. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ and Powell MB: Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 118: 3660-3670, 2008.
25. Baddela VS, Baufeld A, Yenuganti VR, Vanselow J and Singh D: Suitable housekeeping genes for normalization of transcript abundance analysis by real-time RT-PCR in cultured bovine granulosa cells during hypoxia and differential cell plating density. Reprod Biol Endocrinol 12: 118, 2014.
26. Guan Z, Ding C, Du Y, Zhang K, Zhu JN, Zhang T, He D, Xu S, Wang X and Fan J: HAF drives the switch of HIF-1 to HIF-2 by activating the NF-B pathway, leading to malignant behavior of T24 bladder cancer cells. Int J Oncol 44: 393-402, 2014.
27. Xie M, He CS, Wei SH and Zhang L: Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo. Eur J Cancer 49: 3559-3572, 2013.
28. Yang Y, Yan X, Duan W, Yan J, Yi W, Liang Z, Wang N, Li Y, Chen W, Yu S, et al: Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells. PLoS One 8: e62652, 2013.
29. Zhang S, Yang Y, Liang Z, Duan W, Yang J, Yan J, Wang N, Feng W, Ding M, Nie Y, et al: Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLoS One 8: e83699, 2013.
30. Aboagye EO: Positron emission tomography imaging of small animals in anticancer drug development. Mol Imaging Biol 7: 53-58, 2005.
31. Semenza GL: HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123: 3664-3671, 2013.
32. Maroni P, Matteucci E, Drago L, Banfi G, Bendinelli P and Desiderio MA: Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1alpha stabilization/nuclear translocation in bone metastasis from breast carcinoma. Exp Cell Res 30: 287-299, 2015.
33. Seeber LM, Horrée N, Vooijs MA, Heintz AP, van der Wall E, Verheijen RH and van Diest PJ: The role of hypoxia inducible factor-1alpha in gynecological cancer. Crit Rev Oncol Hematol 78: 173-184, 2011.
34. Miyazawa M, Yasuda M, Fujita M, Hirasawa T, Kajiwara H, Hirabayashi K, Ogane N, Shimizu M, Asanuma H, Murakami M, et al: Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: A quantitative analysis of HIF-1. Arch Gynecol Obstet 279: 789-796, 2009.
35. Semenza GL: Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2: 336-361, 2010.
36. Mandl M, Kapeller B, Lieber R and Macfelda K: Hypoxiainducible factor-1 (HIF-1) is upregulated in a HIF-1-dependent manner in 518A2 human melanoma cells under hypoxic conditions. Biochem Biophys Res Commun 434: 166-172, 2013.
37. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M and Wenger RH: Induction and nuclear translocation of hypoxiainducible factor-1 (HIF-1): Heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci 112: 1203-1212, 1999.
38. Liang X: EMT: New signals from the invasive front. Oral Oncol 47: 686-687, 2011.
39. Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster JC: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271, 2004.
40. Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C, Scorilas A and Klinakis A: A new tumor suppressor role for the Notch pathway in bladder cancer. Nat Med 20: 1199-1205, 2014.
41. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and Chodosh LA: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005.
42. Dhillon T, Palmieri C, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Frank J and Seckl MJ: Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 51: 879-887, 2006.
43. Froeling FE and Seckl MJ: Gestational trophoblastic tumours: An update for 2014. Curr Oncol Rep 16: 408, 2014.
44. Lasnon C, Dugue AE, Briand M, Blanc-Fournier C, Dutoit S, Louis MH and Aide N: NEMA NU 4-optimized reconstructions for therapy assessment in cancer research with the Inveon small animal PET/CT system. Mol Imaging Biol 17: 403-412, 2015.